PRIME MEMBER EXCLUSIVE | 3 Months Free Trial

Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals cover art

Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals

Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals

Written by: TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter
Listen for free

Your trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.

This podcast series from TRC Healthcare, the team behind Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights products, is designed to help pharmacists, pharmacy technicians, prescribers, and even patients navigate some of the claims they might see about medication therapy.

Find the video version of this show on YouTube: https://www.youtube.com/@trc.healthcare


TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

© 2026 TRC Healthcare Education Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Ivermectin

    Ivermectin
    Jun 16 2026
    Ivermectin Is Back in the Conversation—But What Should Healthcare Teams Know?From expanded OTC access in some states to persistent online claims, ivermectin is once again popping up in patient conversations—and bringing plenty of confusion with it.In this episode, Don and Steve dig into what’s driving the buzz and what the evidence actually shows across a surprisingly wide range of uses. From viral misinformation to emerging global health research, they explore where ivermectin fits… and where it doesn’t.Along the way, they tackle one of the biggest challenges in practice: how to respond when patients ask about therapies fueled more by headlines than high-quality data—and how to keep those conversations grounded, practical, and patient-centered. Plus, they feature insights from an oncology specialist on real-world patient scenarios.🦠 Is ivermectin still being used for COVID-19—and what does the latest evidence really show?🧬 How should healthcare professionals respond to patients asking about ivermectin for cancer?💊 When might oral ivermectin make sense for certain conditions, like rosacea?🌍 Could ivermectin help reduce malaria transmission—and why does context matter?Let’s worm through the data and track down what holds up—and what doesn’t.They put these claims under the microscope:Ivermectin prevents and cures COVID-19.Ivermectin prevents and cures cancer.Oral ivermectin may improve rosacea.Ivermectin can reduce malaria transmission.🏷️ Our listeners can get 10% off a new or upgraded subscription with code rvt1026 at checkout. ******TRC Healthcare Editor Hosts: Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC Don Weinberger, PharmD, PMSP******Guest: Leslie Gingo, PharmD, BCPS******CE Information:None of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Chart: COVID-19 VaccinesChart: Managing Cough and Cold SymptomsCE Course: Supplements During Cancer TreatmentCE Course: Lifestyle and Cancer RiskChart: Treatments for RosaceaCE Course: Managing Common Travel-Related IllnessesToolbox: Resources for Discussing Medical Misinformation******Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 If you're a student, good news—students can access a free version of Pharmacist’s Letter. ******Rumor vs Truth is a production of TRC Healthcare.Send us Fan MailEmail us: rumorvstruth@trchealthcare.comThe content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.Learn more about our product offerings at trchealthcare.com.
    Show More Show Less
    27 mins
  • BONUS: Mailbag - Is gabapentin toxic in pets?

    BONUS: Mailbag - Is gabapentin toxic in pets?
    Jun 4 2026

    Send us Fan Mail

    Gabapentin is showing up more often in veterinary care —but that raises an important question:

    Is gabapentin toxic in animals?

    In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about gabapentin use in pets. Hosts Don Weinberger, PharmD and Steve Small, PharmD dig into what’s really behind concerns about toxicity—and bring in veterinary toxicology expert Dr. Tina Wismer to help clarify the risks.

    Together, they discuss:

    • Why gabapentin is used in dogs and cats
    • Where these toxicity concerns come from
    • The role of xylitol in certain liquid formulations—and why this matters
    • Why dogs, but not cats, are affected by xylitol
    • What pharmacists and clinical teams should watch for when dispensing
    • What pet owners should do if exposure is suspected

    No CE credit is available for this bonus episode.
    CE credit is available for our full gabapentin episode.

    ******

    🎧 Related Episode (CE Available)

    • Rumor vs Truth: Gabapentin
      (The nerve of gabapentin, is it really as safe as we assumed?)
      🎧Listen: https://rumorvstruth.buzzsprout.com/episodes/19192704
      ▶️ Watch: https://youtu.be/0G9FU99me48

    ******

    TRC Healthcare Editor Hosts

    • Steve Small, PharmD, BCPS, BCPPS, BCCCP, CNSC
    • Don Weinberger, PharmD, PMSP

    Guest

    • Tina Wismer, DVM, MS, DABVT, DABT
      • Senior Director, ASPCA Poison Control

    ******

    Clinical Resources:

    • FAQ: Med Considerations for Cats and Dogs

    🏷️ Our listeners can get 10% off a new or upgraded subscription with code rvt1026 at checkout.

    ******

    Send us Fan Mail

    Email us: rumorvstruth@trchealthcare.com

    The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

    Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

    Learn more about our product offerings at trchealthcare.com.
    Show More Show Less
    6 mins
  • Gabapentin

    Gabapentin
    May 19 2026
    Gabapentin has become a go-to option across a wide range of clinical scenarios—but how well does it actually hold up under closer scrutiny?In this episode, Don Weinberger and Steve Small take a closer look at how gabapentin performs in real-world use—and where expectations may not match the data.🧠Does gabapentin meaningfully improve neuropathic pain outcomes—or are we overestimating its impact in everyday practice?⚠️ How should clinicians interpret safety concerns like dependence, cognitive effects, and mood changes when counseling patients?🔍 Are we using gabapentin for the right types of pain—or defaulting to it when evidence is limited?We’ll break down the data, challenge common assumptions, and follow the evidence wherever it leads—so you can separate clinical signal from background noise when evaluating gabapentin.Key claims explored in this episode include:Gabapentin is modestly effective for neuropathic painGabapentin is addictiveGabapentin causes dementiaGabapentin is associated with suicidal behaviorYou’ll also get quick clinical insights on:Cardiovascular risk signals linked to gabapentin useWhether gabapentin plays a role in treating anxiety disorders🏷️ Our listeners can get 10% off a new or upgraded subscription with code rvt1026 at checkout. ******TRC Healthcare Editor Hosts:Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC Don Weinberger, PharmD, PMSP******Guest: Adam Kaye, PharmD, FASCP, FCPhA******CE Information:None of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim Credit******The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Chart: Pharmacotherapy of Neuropathic PainFAQ: Treating FibromyalgiaCE: Controlled Substance Prescription ValidationChart: Potentially Harmful Drugs: Beers CriteriaAlgorithm: Treatment of HypertensionChart: Pharmacotherapy of Anxiety Disorders******Suicide & Crisis Lifeline - Call or Text: 988https://988lifeline.org/******Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 If you're a student, good news—students can access a free version of Pharmacist’s Letter. ******Rumor vs Truth is a production of TRC Healthcare.Send us Fan MailEmail us: rumorvstruth@trchealthcare.comThe content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.Learn more about our product offerings at trchealthcare.com.
    Show More Show Less
    28 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet